Inactive Instrument

Zeltia SA Stock

Stocks

ES0184940817

Biotechnology & Medical Research

End-of-day quote BME
- ^EUR	-

15-11-11	Alibaba's Singles' Day sales surge 60 percent to $14.3 billion	RE
15-11-03	Alibaba : China consumers to spend more in November 11 'Singles Day' shopping spree - Nielsen	RE

Latest news: Zeltia SA

15-11-11	Alibaba's Singles' Day sales surge 60 percent to $14.3 billion	RE
15-11-03	Alibaba : China consumers to spend more in November 11 'Singles Day' shopping spree - Nielsen	RE
14-12-16	Hyundai Heavy : Thomson Reuters/INSEAD Asia Business Sentiment Survey fourth quarter 2014 - PDF	RE
14-12-16	Hyundai Heavy : Thomson Reuters/INSEAD fourth quarter Asian Business Sentiment Survey - by economy	RE
14-12-16	Hyundai Heavy : Thomson Reuters/INSEAD fourth quarter Asian Business Sentiment Survey - by sector	RE
14-11-03	Inditex : Daughter of Zara founder declares 5 percent Inditex stake	RE
14-02-05	Bell Aliant Inc : Canada tightens rules on cellphone towers	RE
13-12-17	Vodafone Group plc : Insight - The Luxembourg tax break that helps firms profit from loss	RE
13-10-18	Google Inc : Google shares break $1,000 barrier as mobile pays off	RE
13-10-18	Berkshire Hathaway Inc. : Google shares break $1,000 barrier as mobile pays off	RE
13-10-18	Canadian Solar Inc. : China's pioneers to drive recovery in solar equipment demand	RE
13-10-16	Verizon Communications Inc. : Telecom tycoon says Ottawa's policy imperils Wind, foreign investment	RE

Press Releases: Zeltia SA

15-10-26	Zeltia : PharmaMar to Present New Studies for YONDELIS® and PM1183 in Ovarian Cancer during ESGO 2015	PU
15-10-23	Zeltia : U.S. FDA Approves YONDELIS® (trabectedin) for Soft Tissue Sarcoma (Liposarcoma or Leiomyosarcoma)	PU
15-10-21	Zeltia : Grupo Zeltia reports 126.8 million euro in net sales (+8.5%) in the first nine months of 2015	PU
15-09-21	Zeltia : Enrollment of first patient in a Phase II trabectedin study in brain tumor type called meningioma	PU
15-09-17	Zeltia : PharmaMar initiates a phase II “Basket” trial for PM1183 in selected advanced solid tumors	PU

More press releases

News in other languages: Zeltia SA

15-12-14	DJ Industrial : Wall Street termine dans le vert une séance volatile
15-11-17	China CITIC Bank : Les valeurs à suivre sur les marchés américains
15-07-28	DJ Industrial : Wall Street finit en hausse, les craintes sur la Chine refluent
15-07-27	DJ Industrial : Wall Street plombée par la chute des Bourses chinoises
15-05-26	Les valeurs à suivre sur les marchés américains

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	LONZA GROUP AG	+0.22%	-3.17%	-1.61%	+8.24%	45.81B
	REVOLUTION MEDICINES, INC.	-4.36%	-5.66%	+338.30%	+533.43%	43.91B
	IQVIA HOLDINGS INC.	-0.32%	+4.61%	+43.90%	+28.41%	44.39B
	BEONE MEDICINES AG	+0.46%	-0.83%	+6.38%	+66.62%	39.4B
	CELLTRION, INC.	-0.17%	-3.22%	+9.45%	+38.69%	31.26B
	ASCENDIS PHARMA A/S	+3.30%	-5.03%	-	-	15.75B
	MEDPACE HOLDINGS, INC.	-0.65%	+5.14%	+25.61%	+125.72%	17.32B
	EUROFINS SCIENTIFIC SE	+1.66%	+4.92%	+18.42%	+34.93%	14.73B
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.19%	-1.77%	+80.35%	+29.84%	13.03B
	Average	+0.02%	-1.08%	+65.10%	+108.24%	29.51B
	Weighted average by Cap.	-0.46%	-1.10%	+76.20%	+127.99%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!